Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 9;16(2):e0246357. doi: 10.1371/journal.pone.0246357

Inclusion of soybean and linseed oils in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet

Mauricio X S Oliveira 1,#, Andre S V Palma 1,#, Barbara R Reis 1,#, Camila S R Franco 1,#, Alessandra P S Marconi 1,#, Fabiana A Shiozaki 1,#, Leriana G Reis 1,#, Marcia S V Salles 2,#, Arlindo S Netto 1,*,#
Editor: Juan J Loor3
PMCID: PMC7872270  PMID: 33561133

Abstract

Fluid milk and its derivatives are important dietary ingredients that contribute to daily nutrient intake of the modern Homo sapiens. To produce milk that is healthier for human consumption, the present study evaluated the effect of adding soybean oil and linseed oil in the diet of lactating cows. The fatty acid profile of milk, milk composition, and the blood parameters of cows were evaluated. Eighteen Holstein cows were distributed in a replicated Latin square design and distributed according to the following treatments: 1) Control (CC): traditional dairy cow diet, without addition of oil; 2) Soybean oil (SO): 2.5% addition of soybean oil to the traditional diet, as a source of omega-6; 3) Linseed oil (LO): 2.5% addition of linseed oil in the diet as a source of omega-3. Milk production was not affected, but oil supplementation decreased feed intake by 1.93 kg/cow/day. The milk fat percentage was significantly lower when cows were supplemented with vegetable oil (3.37, 2.75 and 2.89% for CC, SO and LO, respectively). However, both soybean and linseed oils decreased the concentration of saturated fatty acids (66.89, 56.52 and 56.60 g/100g for CC, SO and LO respectively), increased the amount of unsaturated fatty acids in milk (33.05, 43.39, and 43.35 g/100g for CC, SO and LO respectively) and decreased the ratio between saturated/unsaturated fatty acids (2.12, 1.34, and 1.36 for CC, SO and LO respectively). Furthermore, SO and LO increased significantly the concentration of monounsaturated fatty acids (29.58, 39.55 and 39.47 g/100g for CC, SO and LO respectively), though it did not significantly alter the level of polyunsaturated fatty acids in milk fat (3.57, 3.93 and 3.98 g/100g for CC, SO and LO respectively). Supplementation with LO enhanced the concentration of omega-3 fatty acids on milk (0.32, 0.36, and 1.02 for CC, SO and LO respectively). Blood variables aspartate aminotransferase, gamma glutamyl transferase, urea, albumin, creatinine and total proteins were not altered. On the other hand, total cholesterol, HDL and LDL were greater in the group supplemented with vegetable oils. Supplementation with vegetable oils reduced the dry matter intake of cows, the fat content of milk, and improved saturated/unsaturated fatty acid ratio of milk fat. Compared to the SO treatment, animals fed LO produced milk with greater content of omega-3, and a more desirable omega-6/omega-3 ratio on a human nutrition perspective. Thus, the inclusion of SO and LO in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human consumption.

Introduction

The fatty acid (FA) profile of the human diet has changed considerably since the industrial revolution [1]. The requirements for practicality and fast meal preparation have led to increased intake of industrial foods, that are typically rich in saturated and omega-6 FAs [2]. In the last 100 to 150 years, the absolute and relative change of omega-6 and omega-3 fatty acids in the food supply of Western societies have led the Western diet to reach a ratio of 20:1 omega-6 and omega-3 [3], which is greater than the 5:1 to 10:1 recommended by the World Health Organization [4]. Some studies suggests that diets rich in saturated and omega-6 fatty acids might shift the physiological state to one that is pro-inflammatory, pro-thrombotic, and pro-aggregatory, with increase in blood viscosity, vasospasm, and vasoconstriction, which are factors associated with the development with coronary heart disease [5] and other non-infectious diseases [6]. Hence, increasing omega-3 polyunsaturated fatty acid (PUFA) consumption, as well as lowering intakes of saturated fat and omega-6 PUFA is desirable [7].

Historically, milk from domestic cows has been an important nutrient source for over 8,000 years in human societies exploiting dairy breeds. It is believed that this relation has led to a geneculture coevolution between domestic cattle and human culture [8]. Nevertheless, in the last decades, a trend to decrease in fluid milk consumption is observed in certain countries, like the United States and Canada [911]. The claimed negative health effects that have been attributed to milk and milk products may partly explain this trend. This criticism has arisen especially because milk fat contains a high fraction of saturated fatty acids, which is assumed to contribute to heart diseases, weight gain, and obesity [12]. Since more dietary PUFA, especially omega-3, might decrease occurrence of coronary and non-infectious disease [4,5], there has been a great deal of interest in manipulating the fatty acid profile of milk fat to respond to consumer demand [13,14].

There are two essential fatty acids in human nutrition: linoleic acid (C18:2 omega-6) and alpha-linolenic acid (C18:3 omega-3) [15]. Humans must obtain essential fatty acids from foods because the human body cannot synthesize it [15]. Linoleic acid is prevalent in corn, sunflower, and mainly in soybean oil, whereas alpha-linolenic acid is predominating in canola, rapeseed, fish oil, and in linseed oil [16]. The use of polyunsaturated oils in the ruminant diet has been shown to be an efficient alternative to enhancing the lipid composition of milk [17,18].

Enhancing the FA profile of milk is beneficial for the dairy industry [19]. Nevertheless, ruminal biohydrogenation (RB), which transforms unsaturated fatty acids (UFA) into saturated fatty acid (SFA), is a major obstacle on improving the nutrition value of milk. The RB process has long been known to occur in the rumen, the first compartment of the ruminant stomach, as the result of microbial metabolic activity [20]. However, there is a limitation on the RB of UFA, and some UFA leave the rumen without being bio-hydrogenated, which means that there might be some potential to enhance the healthiness of ruminant meats and milk by increasing their PUFA composition, particularly omega-3 FA [21].

Dietary FAs can be further processed in the ruminant mammary tissue. The enzyme stearoyl-CoA desaturase in the mammary secretory cell of the mammary gland introduces a cis-double bond exclusively at the Δ9 position of fatty acid [22]. This reaction results in conversion of SFA to monounsaturated fatty acid (MUFA) and specific conjugated linoleic acid (CLA) isomers only found in ruminant products [23]. The predominant CLA isomer in milk fats is rumenic acid (cis-9, trans-11 C18:2), and the majority of milk CLA is derived by de novo synthesis in the mammary gland by Δ9 desaturation of vaccenic acid (trans-11 C18:1) arising from RB [24]. It is believed that certain CLA can contribute to human health. For instance, rumenic acid exhibits anticarcinogenic and antiatherogenic properties in animal models [25].

The objective of this study was to evaluate the effect of the inclusion of soybean oil, as a source of omega-6 FA, and linseed oil, as a source of omega-3 FA, in the diet of lactating cows on milk production, milk composition, milk fatty acid profile, and blood parameters of lactating dairy cows under tropical conditions. Our hypothesis is that supplementing dairy cows with vegetable oils will enhance the FA profile of milk by decreasing the saturated fatty acid content (e.g. C10:0, C12:0, C14:0, C16:0) and increasing the unsaturated fatty acid content (e.g. C18:2 cis9 cis 12, C18:2 cis9 trans11, and C18:3 omega-3).

Material and methods

The Ethics Committee on Animal Experimentation at the Faculty of Animal Science and Food Engineering, University of São Paulo approved this project, under the protocol number 4939070317.

Study design

This study was conducted at Dairy Cattle sector in the University of São Paulo, Campus Fernando Costa, in the city of Pirassununga, São Paulo, Brazil (21°57’19.5"S and 47°27’10.2"W). The minimum and maximum temperature recorded during the study period were respectively 15.2 and 27.7°C.

A total of eighteen lactating Holsteins dairy cows, with an initial body weight mean of 616.33 ± 152 kg, mean body condition score of 3.25, and mean initial milk yield of 26.46 ± 6 kg/day, were selected and housed in the stall barn. Study animals were distributed on a 6 contemporary, 3x3 Latin square design, with the experimental unit being animal during each experimental period (n = 54 experimental units). The study lasted for 94 days. The first ten days were designed for adaptation of animals to the stalls, in which they were kept during the whole study. During this interval, all animals were fed the same diet. The remaining 84 days corresponded to three experimental periods consisting of 28 days each, whereas the first 21 consisted on adaptation to the new diet, and the seven remaining days were designed for data and sample collection.

The treatments consisted of the following experimental diets: 1) Control (CC): traditional dairy cow diet, with no addition of oil; 2) Soybean oil (SO): 2.5% addition of soybean oil to the traditional diet, as a source of omega-6; 3) Linseed oil (LO): 2.5% addition of linseed oil in the diet as a source of omega-3. Both of SO and LO were added in the order of 2.5% of the total dry matter, in the substitution of 2.5% of corn, as shown in Table 1. These levels were chosen because according to previous studies from our research group [13,14], they could enhance the milk FA profile without significantly altering production parameters of dairy cows, e.g. milk yield.

Table 1. Ingredients proportion and chemical composition of the experimental diets expressed on dry matter percentage.

Treatment1
Ingredients % CC SO LO
Ground Corn 30.5 28.0 28.0
Soybean Meal 17.0 17.0 17.0
Soybean Oil - 2.50 -
Linseed Oil - - 2.50
Urea 0.50 0.50 0.50
Limestone 0.30 0.30 0.30
Dicalcium Phosphate 0.15 0.15 0.15
Salt 0.50 0.50 0.50
Mineral Complex2 1.05 1.05 1.05
Corn Silage 50.00 50.00 50.00
Chemical Composition DM%
Dry Matter 92.01 92.61 91.68
Mineral Matter 3.38 3.19 3.18
Crude Protein 16.64 16.15 16.24
Neutral Detergent Fiber 29.97 29.48 29.42
Acid Detergent Fiber 18.73 18.14 17.99
Ether Extract 3.49 5.67 5.78
Lignin 3.91 3.56 3.61
Total Carbohydrate 75.95 74.01 74.18
Non-Fiber Carbohydrate 45.99 44.53 44.76
Total Digestible Nutrients 66.77 69.31 69.46

1 CC = Control; SO = Soybean Oil; LO = Linseed Oil

2 Composition per kilogram of product: Sulfur (S) 80g, Magnesium (Mg) 20g, Potassium (K), 20g, Manganese (Mn) 1000mg, Zinc (Zn) 2500 mg, Copper (Cu) 1500 mg, Cobalt (Co) 100mg, Iodine (I) 80 mg, Selenium (Se) 20 mg, Calcium (Ca) 180g, Phosphorus (P) 90 g, Fluor (F) 300mg.

In the present study, soybean and linseed oil had a total of 84.2% and 88.4% of unsaturated fatty acids (UFA), respectively. Experimental diets were formulated according to the recommendations of the National Research Council for dairy cattle [26] (Holstein in lactation, body weight: 680 kg, milk production: 30 kg/day, dry matter intake: 19.4 kg/day or 2.86% of body weight). The diets consisted of 50% experimental concentrate and 50% corn silage. The experimental diets and water were provided ad libitum. The ingredients and chemical composition of the diet are given on Table 1.

Animals were separated by electric fences to allow individual feed intake measurement. Animals were milked twice a day, at 07:00 and 15:00. Detection of clinical mastitis was performed daily through the black mug test [27], before each milking. Animals were fed individually twice a day, right after milking. The amount of feed given each day was determined by their individual dry matter intake from the previous day, and the percentage of dietary leftovers calculated to be kept between 10 and 20% of the total feed supplied, so that there was no consumption limitation.

Feed assay

Daily samples of the feed and orts were collected and pooled over on every collection period. Feed samples were mixed and sub-sampled, and then stored on a -21°C freezer for subsequent chemical analysis. At the end of the study, samples were defrosted and dried at 65°C in a forced-air oven for 72 h and then grounded on a 1 mm screen mill (Wiley® Mill, Thomas Scientific, Swedesboro NJ, United States). Dry matter (AOAC, 950.15), ash (AOAC, 942.05), ether extract (EE; AOAC, 920.39), crude protein (CP; AOAC, 984.13), acid detergent fiber (ADF), and lignin (AOAC, 973.18) were analyzed in the feed offered and in samples of orts according to the methods described by the Official Methods of Analysis of AOAC International [28]. The neutral detergent fiber (NDF) content of feed and orts were determined by using α-amylase and with no addition of sodium sulphite [29,30] using the Ankon®system (ANKOM Technology, Macedon NY, USA).

Milk production and composition

Milk production corresponded to the sum of the production of the two daily milks, which were measured on an electronic flow meter (DeLaval, Tumba, Sweden) of mechanical milking machine. The results were imported through the Alpro program (DeLaval, Tumba, Sweden) and saved on Microsoft Excel (Microsoft Corporation, Redmond WA, United States) spreadsheets. At each experimental collection period, daily, for each animal, one milk sample was collected during each milking, and mixed in a proportion of 60/40 for morning and afternoon. This collection was done during three consecutive days, on 100 mL collector tubes, containing 2-bromo- 2-nitropropane-1.3-diol (0.05%, wt/vol) preservative.

Milk samples were analyzed for fat, protein, lactose, total solids by the infrared absorption process Bentley 2000 analyzer (Bentley Instruments, Inc. Chaska, Minnesota, USA) [31]; urea nitrogen by spectrophotometric enzymatic method using the ChemSpec 150 analyzer [32], and somatic cell count by flow cytometry using the Bentley 2000® and Somacount 300® apparatus [33]. The defatted dry extract (ESD) was obtained by the difference in fat content and total milk solids.

Fatty acid and cholesterol assay

Milk samples were subjected to determination of cholesterol and fatty acids profile according to the methodology proposed by [34]. Milk samples were collected on a plastic vial with no preservative on it and then frozen on a -20°C freezer until the end of the study. At the end of the study, samples were unfrozen and extraction of fat was conducted according to [35] and methylated according to [36].

Cholesterol determination was conducted according to the methodology proposed by [37]. In short, to the previously thawed and homogenized milk (10g), 8 ml of 50% KOH solution and 12 ml of ethyl alcohol were added, and the solution was placed in a water bath at 60˚C under constant agitation for 15 minutes. Then, 10 mL of distilled water was added until complete cooling. The extraction was carried out with hexane under intense agitation. After separation, a sample of 4 ml of the hexane phase was removed, dried over N2, and mixed with 0.5 ml of isopropanol until complete solubilization. To quantify cholesterol using the enzymatic methodology, the Laborlab® kit was used, composed of two color reagents, in addition to the enzymatic reactive. After the procedure specified by the kit, an absorbance reading was performed against the blank, also prepared at 499 nm. The standard curve was constituted from a standard cholesterol solution (1.006 mg/100mL), with concentration ranging from 0.01 to 0.08 mg / mL.

The FA profile of milk, soybean oil, linseed oil, and total diets were determined by gas chromatography (ThermoFinnigan®, model Trace 2000) using a fused silica capillary column, SP-2560 (100mm x 0.25 mm x 0.2 mm, supelco) and flame ionization detector (FID). Hydrogen was used as carrier gas at a flow rate of 1.8 mL/min. The oven temperature program was an initial 70°C with a holding time of 27 minutes, 215°C (4°C/minute) with a holding time of 9 minutes, and finally, an increase by 7°C/minute to 230°C, standing for five minutes for a total of 65 minutes. Vaporizer and detector temperature were 250°C and 300°C, respectively.

Certified standard butter fat (CRM-164, Commission of the European Communities, Community Bureau of Reference, Brussels, Belgium) was used to determine the recovery of FA and to calculate correction factors. Concentrations of fatty acids are expressed as g/100 g of the total fatty acid concentration. The FA profile of soybean oil, linseed oil, and silage, as well as total SO and LO is shown on Table 2.

Table 2. Fatty acid composition (g/100 g total fatty acids) of experimental diets, soybean oil, linseed oil, and silage.

Fatty Acid Treatment1 Soybean oil Linseed oil Silage
CC SO LO
C6:0 0.08 0.02 0.02 NI2 NI <0.01
C8:0 0.02 <0.01 <0.01 NI NI 0.07
C10:0 NI <0.01 <0.01 NI NI 0.08
C12:0 0.01 <0.01 <0.01 <0.01 <0.01 0.43
C12:1 NI NI NI NI NI NI
C13:0 NI NI NI NI NI <0.01
C13 anteiso NI NI NI NI NI NI
C14:0 0.08 0.09 0.00 0.08 0.05 0.39
C15:0 0.03 0.02 0.03 0.01 0.02 0.10
C15 anteiso NI NI NI NI NI 0.05
C15 iso NI NI NI NI NI 0.05
C16:0 16.09 13.6 10.58 11.13 5.97 19.56
C16 iso 0.01 <0.01 NI 0.01 <0.01 0.03
C16:1 c-9 0.12 0.10 0.10 0.05 0.05 0.25
C17:0 0.10 0.09 0.08 0.06 0.04 0.25
C17 iso NI NI NI NI NI 0.01
C17:1 0.03 NI NI 0.04 0.04 0.04
C18:0 2.92 3.33 3.95 3.56 5.05 3.13
C18:1 cis-9 36.20 27.47 26.6 23.18 20.34 20.24
C18:1 cis-11 1.20 1.40 1.08 1.69 0.89 1.06
C18:1 cis-12 0.11 0.07 0.09 0.10 0.09 0.10
C18:1 cis-13 0.01 0.03 0.02 0.05 0.02 0.02
C18:2 cis-9 cis-12 39.67 47.19 26.68 52.91 13.62 43.27
C18:3 n-3 0.21 0.03 29.85 5.92 53.38 0.29
C18:3 n-6 NI <0.01 NI 0.02 NI NI
C20:0 0.49 0.33 0.25 0.31 0.14 0.79
C20:1 1.93 5.65 NI 0.26 NI 6.34
C21:0 NI NI NI NI NI 0.02
C22:0 0.10 0.16 0.10 0.36 0.13 0.26
C23:0 NI 0.04 0.03 0.04 0.02 0.12
C24:0 0.30 0.18 0.19 0.13 0.09 0.70
C24:1 NI NI <0.01 NI NI 0.01

1 CC = Control; SO = Soybean Oil; LO = Linseed Oil

2 NI = Not identified.

The nutritional quality of the lipid fraction was assessed using the atherogenicity index:

  • AI = (C12:0 + (4 × C14:0) + C16:0)/ (ΣMUFAs) + Σω6 + Σω3)

and thrombogenicity index [38]:

  • TI = (C14:0 + C16:0 + C18:0)/[(ΣMUFAs × 0.5) + (0.5 × Σω6) + (3 × Σω3) + (Σω3/Σω6)]

and the ratio of hypocholesterolemic to hypercholesterolemic fatty acids [39]

  • h/H = [(C18:1 cis-9 + C18:2 ω6 + C18:3 ω3 + C20:5 ω3 + C22:6 ω3)/(C14:0 + 16:0)]

Blood metabolites

Approximately 30 ml of blood were collected at the last day of each experimental period, via puncture in the coccygeal vein. The samples were collected into two 10 ml tubes with no anticoagulant, and one 10 ml tube with fluoride. After collection, the samples were centrifuged at 2,000 g for 15 minutes at a temperature of 4°C to obtain the plasma, which was packed into 2 ml tubes of the eppendorf type and frozen at -20°C freezer. Triglycerides, urea, urea nitrogen, glucose, albumin, total protein, total cholesterol, HDL, LDL, creatine, gamma glutamyl transferase (GGT), aspartate aminotransferase (AST) were determined by commercial kits (Randox®, Crumlin, United Kingdom) using colorimetric methods enzymatic or enzymatic kinetics. The reading was performed in an automatic blood biochemistry analyzer (SBA-200—CEL® Automatic Biochemistry System) and in microplate reader (Asys Mark, Model Expert Plus—UV).

Statistical analysis

The results found in each experimental period were converted into the same Microsoft Excel file, imported, and analyzed with SAS (Statistical Analysis System, version 9.0, Cary, North Carolina, United States) [40]. Data were evaluated for residue normality and homogeneity of variances through Proc-Univariate and Proc-Glm. Somatic cell count needed to be transformed into log (10) (SCC-1) to meet the statistical premise of residue normality. After checking the normality of the data, main effects of the treatments were analyzed by the Proc-Mixed command of SAS, according to the following model:

Yijkl=μ+Ti+Qj+A(Q)k+Pl+eijkl

Where:

  • Yijkl = is the observed value;

  • μ = general mean;

  • Ti = fixed treatment effect i, i = 1 to 3;

  • Qj = fixed effect of the Latin square j, j = 1 to 6

  • A (Q) k = random effect of animal k within each Latin square, k = 1 to 18;

  • Pl = fixed effect of period l, l = 1 to 3;

  • eijkl = random error associated with each observation.

Significance was declared when treatment p-value < 0.05. When treatments were significantly different, further investigation was conducted with the aid of the CONTRAST function of Proc-Mixed. The three treatment averages were then compared through two orthogonal linear contrasts, where mean values of the CC treatment were compared to the average of SO and LO on contrast one (C1), while contrast two (C2) compared the average SO treatment with the LO treatment.

Results

Milk fatty acid profile and cholesterol

The effect of diets on the FA profile of milk is shown in Table 3. When compared to the CC treatment, supplementation of SO and LO decreased the content of the following FAs: C6:0, C8:00, C10:0, C12:0, C14:0, and C16:0 (p < 0.01). Similarly, supplementation with both types of vegetable oil decreased the content of odd- and branched chain FAs like C12:1, C13:0, C13:0 anteiso, C15:0, C15:0 iso, and C15:0 anteiso. Furthermore, compared to SO, milk from LO fed cows had greater concentration of C6:0, C8:0, and C10:0 FAs (p = 0.02, p < 0.01, and p = 0.03, respectively). Overall, supplementation of SO and LO decreased the content of short and median chain FA.

Table 3. Effect of vegetable oil on the fatty acid profile of dairy cows’ milk (g/100 g total fatty acids).

Fatty Acid1 Treatment2 SEM3 p-value C14 C25
CC SO LO
C4:0 2.87 2.23 2.49 0.28 <0.01 <0.01 0.14
C6:0 1.84 1.07 1.28 0.08 <0.01 <0.01 0.09
C8:0 1.13 0.58 0.72 0.05 <0.01 <0.01 0.05
C10:0 2.67 1.32 1.60 0.11 <0.01 <0.01 0.07
C10:1 0.30 0.14 0.17 0.01 <0.01 <0.01 0.07
C11:0 0.09 0.29 0.04 0.01 <0.01 <0.01 0.35
C12:0 3.46 1.98 2.22 0.11 <0.01 <0.01 0.14
C12:1 0.10 0.05 0.05 0.09 <0.01 <0.01 0.45
C13:0 0.15 0.08 0.09 0.01 <0.01 <0.01 0.39
C13:0 iso 0.04 0.04 0.04 0.01 0.90 0.73 0.77
C13:0 anteiso 0.08 0.05 0.05 0.01 <0.01 <0.01 0.55
C14:0 10.36 7.59 7.98 0.62 <0.01 <0.01 0.25
C14:0 iso 0.09 0.07 0.08 0.01 0.07 0.02 0.75
C14:1ω9 0.93 0.82 0.76 0.20 0.28 0.14 0.58
C15:0 1.26 0.84 0.88 0.05 <0.01 <0.01 0.56
C15:0 iso 0.22 0.18 0.18 0.02 0.01 <0.01 0.87
C15:0 anteiso 0.59 0.47 0.49 0.05 <0.01 <0.01 0.47
C16:0 29.82 24.63 22.67 2.23 <0.01 <0.01 0.21
C16:0 iso 0.26 0.26 0.25 0.05 0.83 0.89 0.56
C17:0 0.46 0.40 0.38 0.04 0.02 0.01 0.69
C16:1c9 1.86 1.77 1.52 0.19 0.09 0.12 0.12
C17:0 iso 0.39 0.34 0.37 0.01 0.03 0.02 0.14
C17:1 0.21 0.19 0.18 0.01 0.23 0.11 0.52
C18:0 11.28 14.50 14.94 1.18 <0.01 <0.01 0.47
C18:1 trans 3.56 6.80 5.29 0.04 <0.01 <0.01 0.01
C18:1 c9 20.56 27.18 27.97 0.91 <0.01 <0.01 0.55
C18:1 c11 0.90 1.04 0.99 0.06 0.22 0.10 0.55
C18:1 c12 0.38 0.52 0.52 0.02 <0.01 <0.01 0.96
C18:1 c13 0.09 0.15 0.16 0.01 <0.01 <0.01 0.99
C18:1 t16 0.23 0.36 0.77 0.02 <0.01 <0.01 <0.01
C18:1 c15 0.04 0.10 0.65 0.02 <0.01 <0.01 <0.01
C18:2 c9c12 ω6 2.13 2.62 2.03 0.12 <0.01 0.19 <0.01
C18:3 ω6 0.02 0.01 0.01 <0.01 <0.01 <0.01 <0.01
C18:3 ω3 0.31 0.35 0.99 0.03 <0.01 <0.01 <0.01
C18:2 c9t11 0.74 0.65 0.68 0.08 0.42 0.21 0.68
C18:2 t10c12 <0.01 0.03 0.01 <0.01 <0.01 <0.01 <0.01
C20:0 0.14 0.15 0.14 0.02 0.25 0.37 0.15
C20:1 0.03 0.06 0.06 <0.01 <0.01 <0.01 0.25
C20:2 0.01 0.01 0.01 <0.01 0.25 0.17 0.38
C20:3 ω6 0.14 0.11 0.09 0.01 <0.01 <0.01 <0.01
C20:3 ω3 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
C20:4 ω6 0.15 0.08 0.08 <0.01 <0.01 <0.01 0.55
C20:5 ω3 0.03 0.02 0.04 <0.01 <0.01 <0.01 <0.01
C21:0 0.01 <0.01 0.03 <0.01 3.67 <0.01 <0.01
C22:0 0.03 0.03 0.03 <0.01 0.50 0.43 0.37
C22:1ω9 <0.01 <0.01 <0.01 <0.01 0.63 0.86 0.44
C22:5 0.04 <0.01 0.03 <0.01 <0.01 <0.01 0.26
C22:2 <0.01 0.00 0.00 <0.01 0.40 0.18 0.98
C22:6 ω3 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 0.71
C23:0 <0.01 <0.01 <0.01 <0.01 <0.01 0.01 0.04
C24:0 0.03 0.01 0.01 <0.01 <0.01 0.09 <0.01
C24:1 0.02 0.01 0.01 <0.01 0.04 0.01 0.07

1 c = cis; t = trans

2 CC = Control; SO = Soybean Oil; LO = Linseed Oil

3 SEM = Standard Error of the Mean

4 C1 = Contrast 1 (CC vs. SO + LO)

5 Contrast 2 (SO vs. LO).

The concentration of FAs C18:0, C18:1 cis-9, C18:1 cis-12 and C18:1 cis-13 increased when cows were supplemented with either SO or LO. Compared to the CC, the content of C18:1 cis-9 was 32.2 and 36% greater in the SO and SO, respectively (p = 0.01). The content of C18:1 cis-9 did differ between the SO and LO treatment (p = 0.55). When compared to LO, the concentration of C18:2 cis-9 cis-12 increased when cows were supplemented with SO. The concentration of C18:3 omega-3 in the LO treatment were 3.2 times greater compared to the CC (p < 0.01) and 2.18 greater when compared to SO (p < 0.01). Surprisingly, supplementing cows with SO or LO did not increase the content of C18:2 cis-9, trans-11 in milk (p = 0.21).

Supplementation with both SO and LO decreased the percentage of saturated fatty acids and increased the percentage of unsaturated fatty acids in the milk of dairy cows; thereby the ratio between saturated/unsaturated FA was decreased (Table 4). In addition, SO and LO significantly increased the content of MUFA (p < 0.01) and tended to increase PUFA (p = 0.07). The omega-3 family fatty acids content was significantly greater when cows received LO than SO treatment. Lower omega-6/omega-3 ratio was observed when animals were fed LO. Supplementation of SO and LO significantly decreased the atherogenicity and thrombogenicity indexes of milk fat (p < 0.01). Moreover, the ratio of hypocholesterolemic to hypercholesterolemic fatty acids increased (p < 0.01). Compared to the SO treatment, milk cholesterol content from LO fed animals tended to decrease (p = 0.09).

Table 4. Effect of vegetable oil on the quality of the lipid fraction of dairy cows’ milk.

Item Treatment1 SEM2 p-value C13 C24
CC SO LO
ΣCLnA, CLA 3.1656 3.6131 3.6756 0.1828 0.0747 0.0247 0.7923
ΣSFA 66.8867 56.5243 56.6049 1.4408 <0.01 <0.01 0.9691
ΣUFA 33.0507 43.3936 43.3463 1.4379 <0.01 <0.01 0.9857
ΣMUFA 29.5831 39.5512 39.4701 1.3009 <0.01 <0.01 0.9656
ΣPUFA 3.5699 3.9347 3.9786 0.2747 0.1993 0.0761 0.8605
Σω3 0.3244 0.3604 1.0223 0.0292 <0.01 <0.01 <0.01
Σω6 2.4832 2.8805 2.2519 0.208 0.0039 0.5887 0.001
SFA/ UFA 2.1215 1.3412 1.3644 0.107 <0.01 <0.01 <0.01
ω6/ ω3 7.9187 8.263 2.7245 0.5045 <0.01 <0.01 <0.01
AI 5.5693 4.7929 4.8439 0.0883 <0.01 <0.01 0.6899
TI 3.1614 2.1552 1.9669 0.1696 <0.01 <0.01 0.4445
h/ H 0.5969 0.9267 1.0079 0.0859 <0.01 0.01 0.2362
Cholesterol 9.9422 10.0527 8.7411 1.6494 0.1738 0.4029 0.0973

ΣCLnA (g/100g), CLA = CLnA (18:3 ω6 + 18:3 ω3) + CLA (18:2 ω6 + 9c,11t-18:2); ΣSFA(g/100g) = Σ saturated fatty acids; ΣUFA (g/100g) = Σ unsaturated fatty acids; ΣMUFA (g/100g) = Σ monounsaturated fatty acids; ΣPUFA (g/100g) = Σ polyunsaturated fatty acids; Σ ω3 (g/100g) = Σ omega-3 fatty acids; Σ ω6 (g/100g) = Σ omega-6 fatty acids; SFA/UFA = saturated/unsaturated; ω6/ ω3 = Σomega-6/Σomega-3; AI = atherogenicity index; TI = thrombogenicity index; h/H = ratio of hypocholesterolemic to hypercholesterolemic fatty acids; Cholesterol values expressed on mg/100mL.

1 CC = Control; SO = Soybean Oil; LO = Linseed Oil

2 SEM = Standard Error of the Mean

3 C1 = Contrast 1 (CC vs. SO + LO)

4 Contrast 2 (SO vs. LO).

Milk production and composition

The addition of soybean oil and linseed decreased the dry matter intake in lactating cows by 1.93 kg/day (p = 0.02). However, milk production and fat-corrected milk production (FCM) were not affected by treatment (p = 0.85 and p = 0.19, respectively) (Table 5).

Table 5. Effect of vegetable oil supplementation on milk composition and production on dairy cows.

Variable Treatment1 SEM2 p- value C13 C24
CC SO LO
Milk yield (kg) 25.87 26 25.3 1.57 0.8563 0.8426 0.6356
FCM5 22.92 21.26 20.96 1.02 0.1916 0.0725 0.8765
Fat (%) 3.37 2.75 2.89 0.2 <0.01 <0.01 0.3323
Fat kg/day 0.81 0.67 0.68 0.43 0.01 <0.01 0.7367
Protein (%) 3.29 3.35 3.3 0.09 0.3875 0.4157 0.2429
Protein kg/day 0.83 0.84 0.8 0.04 0.6503 0.8118 0.384
Lactose (%) 4.35 4.31 4.37 0.06 0.0616 0.4574 0.0282
Lactose kg/day 1.14 1.13 1.12 0.06 0.8943 0.6515 0.8702
TS6 (%) 12.01 11.25 11.61 0.3 <0.01 <0.01 0.4741
TS kg/day 3.04 2.92 2.86 0.14 0.4673 0.2464 0.7284
SNF7 (%) 8.64 8.75 8.71 0.13 0.1152 0.0489 0.5262
SNF kg/day 2.23 2.24 2.18 0.11 0.8292 0.9122 0.5456
SCC8 (cel/mL) 247.15 231.33 266.09 62.27 0.5244 0.9578 0.2601
MUN9(mg/dL) 14.39 12.23 12.64 0.69 0.5282 <0.01 0.3864

1 CC = Control; SO = Soybean Oil; LO = Linseed Oil

2SEM = Standard Error of the Mean

3C1 = Contrast 1 (CC vs. SO + LO)

4Contrast 2 (SO vs. LO)

5FCM = 4.0% fat-corrected milk

6TS = total solids

7SNF = solids non-fat

8SCC = Somatic Cell Count

9MUN = Milk Urea Nitrogen.

The percentage of fat and the fat yield were reduced with the inclusion SO and LO in the diet of the cows in comparison to the CC (p < 0.01), and there were no differences between the two oils. Similarly, compared to the CC, we observed a reduction in the percentage of total solids in the milk of cows supplemented with SO and LO (p < 0.01). However, this difference was not observed in total solid production in kg/day (p = 0.46).

Supplementation of SO and LO did not influence (p ≥ 0.05) the content or the production of the following components on milk: protein, lactose, and solids non-fat. Similarly, no differences were observed in SCC or the concentration of milk MUN.

Blood metabolites

The effect of supplementation with SO and LO on the metabolic profile of dairy cows is show on Table 6. Compared to the CC treatment, both SO and LO diets significantly increased the cholesterol levels on the plasma of dairy cows (p < 0.01). No statistical differences on cholesterol levels were observed between the SO and LO-fed cows (p = 0.56). Similarly, SO and LO diets increased HDL and LDL concentration on the plasma when compared to the CC treatment (p < 0.01). Still, no significant differences on HDL and LDL were observed when comparing the SO and LO diets (p = 0.49 and p = 0.78, respectively). Compared to the CC treatment, SO and LO treatments did not affect (p ≥ 0.05) the following blood variables: AST, GGT, urea, albumin, creatinine, total proteins, CK, triglycerides, VLDL, and glucose.

Table 6. Effect of vegetable oil on blood parameters of dairy cows.

Variable Treatment1 SEM2 p-value c13 c24
CC SO LO
AST U/L5 72.94 74.88 68.28 2.82 0.29 0.65 0.14
GGT U/L6 33.5 34.75 33.72 2.27 0.92 0.79 0.75
Urea mg/dL 41 38.6 40.17 1.53 0.55 0.40 0.48
Albumin g/dL 3.51 3.49 3.51 0.02 0.90 0.78 0.71
Creatinine mg/dL 1.01 0.99 1.02 0.04 0.72 0.97 0.42
Total Proteins g/dL 7.4 7.29 7.31 0.01 0.71 0.42 0.85
CK U/L7 111.61 139.99 94.72 17.13 0.29 0.90 0.12
Cholesterol mg/dL 149.39 202.15 194.39 9.27 <0.01 <0.01 0.56
Triglycerides mg/dL 12.5 14.57 14.28 0.84 0.19 0.07 0.81
HDL8 mg/dL 73.78 95.26 90.67 8.69 <0.01 <0.01 0.50
LDL9 mg/dL 68.5 96.22 99.24 7.66 0.01 <0.01 0.78
VLDL10 mg/dL 2.44 2.83 2.83 0.18 0.24 0.09 0.98
Glucose mg/ dL 61.99 61.18 62.18 1.34 0.55 0.99 0.28

1CC = Control; SO = Soybean Oil; LO = Linseed Oil

2SEM = Standard Error of the Mean

3C1 = Contrast 1 (CC vs. SO + LO)

4Contrast 2 (SO vs. LO)

5AST = aspartate aminotransferase

6GGT = gamma glutamyl transferase

7CK = creatinine kinase

8HDL = high-density lipoprotein

9LDL = Low-density lipoprotein

10VLDL = Very low-density lipoprotein.

Discussion

Dietary long-chain UFAs have the potential to be incorporated into milk fat, consequently altering the profile of short and long-chain FA and the degree of saturation of milk fat [11,12]. Indeed, the ability to enhance the FA profile of milk fat is limited not by the synthesis capacity of the mammary gland, but rather by effectively having UFA escaping from biohydrogenation in the rumen [41,42]. The FA composition of certain oils, like linseed, is considered desirable from a human health perspective and thus their inclusion in the diet of dairy cattle might represent a mean of achieving a more desirable FA profile in milk fat.

Milk fatty acid profile and cholesterol

Inclusion of SO and LO led to a significant decrease on the content of the following saturated FAs: C4:0, C6:0, C8:00, C10:0, C12:0, C14:0, and C16:0.

According to [43], the short-chain fatty acids (4 to 8 carbons) and medium-chain fatty acids (10 to 14 carbons) content in milk arise almost exclusively from de novo synthesis of FA in the epithelial cells of the mammary gland. On the other hand, long-chain fatty acids (>16 carbons) are derived from the uptake of circulating lipids, and fatty acids of 16 carbons in length originate from both sources [43]. It is suspected that supplementation of UFA in the diet of dairy cows can reduce milk fat content because of the production of certain trans FAs, by incomplete ruminal biohydrogenation of dietary UFA [44]. These trans FA are absorbed into the gut and reach the mammary gland. It is belief that once these trans FAs reach the mammary gland, the expression of lipogenic enzymes (e. g., acetyl-CoA carboxylase and fatty acid synthase) that act in de novo synthesis of fatty acids is reduced [41]. Indeed, in the present study, SO and LO supplementation reduced FA concentration up to C17:0 and increased the concentration of C18:2 trans-10 cis-12, which is one of the trans FAs mainly responsible for the fat reduction in milk [45]. The presence of this FA in milk might indicate a lower lipogenic enzyme activity in de novo synthesis in the epithelial cells of the mammary gland. Other authors [13] have reported similar results. The decrease in C16:0 FA in milk fat, observed with vegetal oil supplementation, might be of interest on a human nutrition perspective because palmitic acid appears to be related to increased blood cholesterol [43]. Cholesterol, in turn, is a complex substance that has many functions in the body [46]. However, an increase and accumulation in the organism can lead to increased concentration in the blood, which can eventually lead to the development of coronary diseases, like atherosclerosis, arterial hypertension, diabetes mellitus and formation of gallstones [47]. The concentration of C16 on milk fat did not differ between the SO and LO treatments.

Similarly to even chain FA with a carbonic chain from C4:0 to C16:0, supplementation with SO and LO also decreased the concentration of odd-chain FA in milk fat. According to [48], ruminal microbes are the main producers of the odd chain FA found in the ruminant tissue and inclusion of PUFA in the diet can alter the rumen environment, which in turn alters microbial fermentation and FA production in the rumen [49]. Supplementation of cis-9, cis-12 18:2 have been shown to affect cellulolytic bacteria [50], and cellulolytic bacteria synthesize iso FA. On the other hand, amylolytic bacteria produce elevated levels of anteiso and linear odd-chain FA while originating relatively low levels of iso FA [51]. We believe that the PUFA supplementation in the present study might have affected the two bacteria population, as both iso and antesio FAs concentration in milk were lower when animals were fed SO and LO. Similarly to our results, other studies where cows were fed soybean oil [52] and linseed oil [53] also found a significant decrease in the concentration of odd-chain fatty acids in milk.

The significant increase of C18:0 concentration on milk observed when cows were fed SO and LO indicates completion of the RB process to a certain extent, given that C18:0 is the final step for complete biohydrogenation of C18:2 cis-9 cis-12 and C18:3 omega-3. On the other hand, many of these fatty acids must pass through the rumen without suffering biohydrogenation or suffering partial biohydrogenation of fatty acids, which is indicated by the significant increase in intermediate FA of RB as trans FA, e.g., C18:2 trans-10 cis-12. On a human nutrition perspective, evidence suggest that stearic acid does not increase serum cholesterol concentration, and is not atherogenic [54,55]. The greater amount of C18:1 cis-9 and its isomers found in the milk of dairy cows fed SO and LO is in agreement with previous research [53,56]. The increase of oleic acid can be the result of partial biohydrogenation of C18:2 and C18:3 FA rumen [17]. Diets with great amounts of monounsaturated FA, like C18:1, have been shown to reduce plasma cholesterol, LDL-cholesterol, and triacylglycerol concentrations on human blood [57]. Moreover, replacement of SFA to cis-unsaturated fatty acids, like 18:1, might reduce risk for coronary artery disease on humans [55].

In the present study, the concentration of PUFA in milk tended to increase when cows were fed SO and LO. Linoleic acid (18:2 omega-6) was greater on milk from SO-fed cows, and alpha-linolenic acid (C18:3 omega-3) concentration was greater on milk from LO-fed cows. Once these PUFA pass the rumen, they are absorbed through the intestinal epithelium. Inside the enterocytes, these PUFAs are again re-esterified into triglycerides and transported via chylomicrons through the lymphatic system and flow to the thoracic duct where they enter the blood system [58]. Unlike other nutrients absorbed from the gastro intestinal tract, dietary FAs enter the general circulation directly and are used by all body tissues, like the mammary gland, without a preliminary processing by the liver. When these PUFAs reach the mammary gland, they will increase the unsaturated fatty acids in milk fat [58]. On a human nutrition perspective, these fatty acids can be beneficial as they can be converted to fatty acids with 20 carbon atoms, like arachidonic acid (C20:4 omega-6) and eicosapentaenoic acid (C20:5 omega-3) [59]. Nevertheless, arachidonic acid, derived from linolenic acid, may enhance blood platelet aggregation; hence, it can increase the coronary risk [60]. Arachidonic acid has the potential to partially block the conversion of omega-6 FAs to harmful eicosanoids. Hence, it can reduce cardiovascular risk and inhibit tumor genesis [61].

The intake ratio of omega-6/omega-3 FA in the human diet was modified throughout the evolution of the species. The Mesolithic man is estimated to have had a ratio of 1–4:1 between the omega-6 and omega-3 FA, whereas most societies nowadays have this ratio varying between 10–14:1 [62]. Indeed, the search for a healthier diet has been the aim of several studies on human health because of numerous cases of non-communicable diseases that trigger the death of thousands of people worldwide [63]. In this perspective, the need for balancing the omega-6/omega-3 ratio is beneficial. Evidence shows that excessive omega-6 intake might lead to pro-inflammatory effects, increasing the production of cytokines with vasoconstriction properties, which promotes platelet aggregation [1]. Indeed, platelet aggregation is related to occurrence of cardiovascular and inflammatory diseases, like arthritis, asthma, and ulcerative colitis [3]. Omega-3 FA, on the other hand, play an essential role in preventing cardiovascular diseases because it produces eicosanoids with less inflammatory power and even anti-inflammatory properties [61]. These eicosanoids promotes vasodilation and inhibits platelet aggregation, which are functions that are also related to the prevention of hypertension, atherosclerosis, hypercholesterolemia, arthritis and other autoimmune and inflammatory diseases as well as various cancers [7]. In the present study, milk of cows fed LO can be a valid option in the search for healthier food items that has the potential to prevent certain coronary diseases. Milk from cows fed LO resulted in an omega-6/omega-3 ratio of 2.7:1, whereas milk from CC-fed cows 7.9:1 and SO was 8.3:1.

Supplementation with SO and LO significantly decreased the atherogenicity and thrombogenicity indexes in the milk of dairy cows. The atherogenicity is the ability to induce atherosclerosis formation, whereas thrombogenicity means the ability to promote heart attacks and strokes [38]. Lower values for both indices are desirable, as the lower the amount of atherogenic fatty acids present in a given fat or oil, the greater the potential for prevention against the development of coronary heart disease [38]. The ratio of hypocholesterolemic to hypercholesterolemic fatty acids index works the opposite way of the previous indexes, the higher the hypocholesterolemic to hypercholesterolemic fatty acids index is, the better nutrition is, and the lower the risk of cardiovascular disease is [39]. There is no recommended value for none of these indices in dairy products. Nevertheless, it is considered that the lower the value of atherogenicity and thrombogenicity indices, and a greater hypocholesterolemic to hypercholesterolemic fatty acids index, the more favorable the FA profile to human health.

Milk production and composition

The decrease in dry mater intake when dairy cows were fed vegetables oil has observed in previous studies [13,64]. The decrease in dry matter intake in the present study might have been caused by the greater lipid content in the SO and LO diets (5.67 and 5.78% of ether extract in the dry mater, respectively) compared to the CC treatment (3.59% of ether extract in the dry matter). Both oils sources have a high content of UFA (84.2 and 88.4%, respectively for soybean and linseed oils), and according to [65], dairy diets containing oil sources rich in unprotected PUFA often causes a decrease in DM intake. The mechanisms behind the decreased dry matter intake are attributed to alteration of ruminal fermentation, gut motility, palatability of added fat diets, release of certain gut hormones, and oxidation of fat in the liver [65]. The reduction of nutrient intake and ruminal fermentation may reduce the rate of digestion and consequently decrease the flow of nutrients arriving to the mammary gland, which in certain cases could reduces milk production. Nevertheless, despite the reduction in dry matter intake caused by the addition of oils in the diets, this effect was not enough to affect milk yield in the present study. Perhaps because the greater content of energy contained in vegetable oils made up for the decrease in dry mater intake. This lack of difference on milk yield when animals are fed diets with high content of oil has also been observed on a recent study from our research group [14].

Inclusion of SO and LO decreased the percentage and the yield of fat in the milk of dairy cows. Compared to the CC, animals fed SO and LO produced 17.3% and 16.0% less milk fat. In contrast to our research, some other previous research did not find such a prominent decrease in the fat content of cows fed vegetable oils. Indeed, the EE % was not over the recommended by [26]. Nevertheless, it is important to note that even though the forage-concentrate ratio was 50:50, corn silage was the only forage source used on our study. According to [43], although corn silage-based diet may contain an adequate level of fiber, its effectiveness to maintain rumen function less than the fiber in grass silage-based diets, which might negatively affect normal milk fat. Additionally, the high proportion of corn grain present is this silage reduces its effectiveness of corn silage as a forage source. Indeed, vegetable oil supplements will not depress milk fat yield if roughage intake is elevated or the effectiveness of roughage fiber is sufficient to maintain normal rumen function [66,67].

The decrease in the percentage of total solids in milk on cows fed SO and LO was likely a reflection to the decreased fat production. Since total solids correspond to the summation of fat, protein, and lactose, a decrease on fat production would affect the total solid percentage directly. The decrease in fat concentration and total solids in the milk might be undesirable for certain sectors of the dairy industry. That is because milk solids is an important component for the production of certain milk derivate, like butter, cream and chesses [68]. On the other hand, the more desirable FA profile of milk fat could classify milk as “functional food”, which could make the product more profitable as consumers from developed countries are attracted to healthier foods [69,70].

Blood metabolites

In the present study, total cholesterol, HDL, and LDL were the metabolites affected by supplementation of SO and LO. This effect was probably observed due to an increase in fatty acid intake caused by vegetable oil supplementation. On the metabolism of ruminants, the unsaturated fatty acids that leave the rumen are absorbed through the intestinal epithelium [42]. In the enterocytes the fatty acids are re-esterified to triacylglycerols and arranged mainly in chylomicrons. Through the lymphatic system they reach the bloodstream, where they will be finally directed to peripheral tissues [42]. Although total cholesterol increased in the present study, HDL levels also increased. HDL is a high-density lipoprotein, and it might work in a beneficial way by mobilizing excess cholesterol present in the blood to the liver. When it reaches the liver, excess cholesterol can be metabolized and thus prevents the accumulation of fat in peripheral tissues of cows. The lack of statistical difference between CC and vegetable oil treatments on other metabolic parameters, like AST and GGT, might mean that SO and LO can be fed in the order of 2.5% of the diet without causing negative effects on the health of dairy cows.

Conclusion

Dietary supplementation with LO increased the concentration of C18:3 omega-3 and decreased the milk omega-6/omega-3 ratio to 2.72. The results found in the present study provide further evidence that the addition of vegetable oils in the ruminant diet makes the fatty acid profile of the milk nutritionally healthier for human diets. Future, studies should evaluate the health benefits of omega-3 and omega-6 enriched milk in the human diet.

Acknowledgments

We are very grateful for the Faculty of Animal Science and Food Engineering for providing the animals and physical structure for the execution of this project.

Data Availability

All relevant data are within the manuscript.

Funding Statement

This work was funded by São Paulo Research Foundation (FAPESP) São Paulo, Brazil, research funding (FAPESP Process 2015/ 19393-8); two scholarships (FAPESP Processes 2016/23735-4 and 2016/23797-0), and one master's scholarship - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), for Mauricio X. S. Oliveira. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Simopoulos AP. Evolutionary Aspects of the Dietary Omega-6/Omega-3 Fatty Acid Ratio: Medical Implications In: Alvergne A, Jenkinson C, Faurie C, editors. Evolutionary Thinking in Medicine. Cham: Springer International Publishing; 2016. pp. 119–134. 10.1007/978-3-319-29716-3_9 [DOI] [Google Scholar]
  • 2.Simopoulos AP. Omega-3 fatty acids in wild plants, nuts and seeds. Asia Pacific Journal of Clinical Nutrition. 2002;11: S163–S173. 10.1046/j.1440-6047.11.s.6.5.x [DOI] [Google Scholar]
  • 3.D APS M. Omega-6/Omega-3 Essential Fatty Acid Ratio and Chronic Diseases. Food Reviews International. 2004;20: 77–90. 10.1081/FRI-120028831 [DOI] [Google Scholar]
  • 4.WHO | Fats and fatty acids in human nutrition In: WHO [Internet]. World Health Organization; [cited 25 May 2020]. Available: https://www.who.int/nutrition/publications/nutrientrequirements/fatsandfattyacids_humannutrition/en/. [Google Scholar]
  • 5.de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343: 1454–1459. 10.1016/s0140-6736(94)92580-1 [DOI] [PubMed] [Google Scholar]
  • 6.Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr. 1997;65: 1011–1017. 10.1093/ajcn/65.4.1011 [DOI] [PubMed] [Google Scholar]
  • 7.Ruxton CHS, Reed SC, Simpson MJA, Millington KJ. The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. Journal of Human Nutrition and Dietetics. 2004;17: 449–459. 10.1111/j.1365-277X.2004.00552.x [DOI] [PubMed] [Google Scholar]
  • 8.Gene-culture coevolution between cattle milk protein genes and human lactase genes | Nature Genetics. [cited 29 Apr 2020]. Available: https://www.nature.com/articles/ng1263. [DOI] [PubMed]
  • 9.Nutrition: Insel, Paul M., Turner, R. Elaine, Ross, Don: 9780763747282: Amazon.com: Books. [cited 29 Apr 2020]. Available: https://www.amazon.com/Nutrition-Paul-M-Insel/dp/0763747289.
  • 10.U.S. fluid milk products consumption per capita, 2019. In: Statista [Internet]. [cited 3 Nov 2020]. Available: https://www.statista.com/statistics/184240/us-per-capita-consumption-of-fluid-milk-products/.
  • 11.Milk: per capita consumption Canada 2018. In: Statista [Internet]. [cited 3 Nov 2020]. Available: https://www.statista.com/statistics/438584/consumption-of-milk-per-capita-canada/.
  • 12.Chang CL, Deckelbaum RJ. Omega-3 fatty acids: mechanisms underlying “protective effects” in atherosclerosis. Curr Opin Lipidol. 2013;24: 345–350. 10.1097/MOL.0b013e3283616364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Welter KC, Martins CM de MR, de Palma ASV, Martins MM, dos Reis BR, Schmidt BLU, et al. Canola Oil in Lactating Dairy Cow Diets Reduces Milk Saturated Fatty Acids and Improves Its Omega-3 and Oleic Fatty Acid Content. Cowart A, editor. PLoS ONE. 2016;11: e0151876 10.1371/journal.pone.0151876 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Salles M, D’Abreu L, Júnior L, César M, Guimarães J, Segura J, et al. Inclusion of Sunflower Oil in the Bovine Diet Improves Milk Nutritional Profile. Nutrients. 2019;11: 481 10.3390/nu11020481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kaur N, Chugh V, Gupta AK. Essential fatty acids as functional components of foods- a review. J Food Sci Technol. 2014;51: 2289–2303. 10.1007/s13197-012-0677-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Freitas JB, Naves MMV. Composição química de nozes e sementes comestíveis e sua relação com a nutrição e saúde. Revista de Nutrição. 2010;23: 269–279. 10.1590/S1415-52732010000200010 [DOI] [Google Scholar]
  • 17.Kennelly JJ. The fatty acid composition of milk fat as influenced by feeding oilseeds. Animal Feed Science and Technology. 1996;60: 137–152. 10.1016/0377-8401(96)00973-X [DOI] [Google Scholar]
  • 18.Shingfield KJ, Chilliard Y, Toivonen V, Kairenius P, Givens DI. Trans Fatty Acids and Bioactive Lipids in Ruminant Milk In: Bösze Z, editor. Bioactive Components of Milk. New York, NY: Springer; 2008. pp. 3–65. 10.1007/978-0-387-74087-4_1 [DOI] [PubMed] [Google Scholar]
  • 19.Haug A, Høstmark AT, Harstad OM. Bovine milk in human nutrition—a review. Lipids Health Dis. 2007;6: 25 10.1186/1476-511X-6-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kellens MJ, Goderis HL, Tobback PP. Biohydrogenation of unsaturated fatty acids by a mixed culture of rumen microorganisms. Biotechnol Bioeng. 1986;28: 1268–1276. 10.1002/bit.260280820 [DOI] [PubMed] [Google Scholar]
  • 21.Côrtes C, da Silva-Kazama DC, Kazama R, Benchaar C, Santos GTD, Zeoula LM, et al. Intake and digestion of fatty acids by dairy cows fed whole flaxseed and Ca salts of flaxseed oil. Animal Feed Science and Technology. 2011;169: 270–274. 10.1016/j.anifeedsci.2011.06.016 [DOI] [Google Scholar]
  • 22.Bernard L, Leroux C, Chilliard Y. Expression and nutritional regulation of Stearoyl-CoA desaturase genes in the ruminant mammary gland: relationship with milk fatty acid composition. 34. [Google Scholar]
  • 23.Palmquist DL, Lock AL, Shingfield KJ, Bauman DE. Biosynthesis of Conjugated Linoleic Acid in Ruminants and Humans Advances in Food and Nutrition Research. Academic Press; 2005. pp. 179–217. 10.1016/S1043-4526(05)50006-8 [DOI] [PubMed] [Google Scholar]
  • 24.Griinari JM, Corl BA, Lacy SH, Chouinard PY, Nurmela KVV, Bauman DE. Conjugated Linoleic Acid Is Synthesized Endogenously in Lactating Dairy Cows by Δ9-Desaturase. J Nutr. 2000;130: 2285–2291. 10.1093/jn/130.9.2285 [DOI] [PubMed] [Google Scholar]
  • 25.Wahle KWJ, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res. 2004;43: 553–587. 10.1016/j.plipres.2004.08.002 [DOI] [PubMed] [Google Scholar]
  • 26.Nutrient Requirements of Dairy Cattle: Seventh Revised Edition, 2001. Washington, D.C.: National Academies Press; 2001. p. 9825 10.17226/9825 [DOI] [PubMed] [Google Scholar]
  • 27.Hillerton JE, Booth JM. The Five-Point Mastitis Control Plan—A Revisory Tutorial! 2018; 137 10.1017/S0022029918000158 [DOI] [PubMed] [Google Scholar]
  • 28.AOAC International. Official methods of analysis of AOAC International. Official methods of analysis of AOAC International.
  • 29.Hall MB, Hoover WH, Jennings JP, Webster TKM. A method for partitioning neutral detergent-soluble carbohydrates. Journal of the Science of Food and Agriculture. 1999;79: 2079–2086. 10.1002/(SICI)1097-0010(199912)79:15&lt;2079::AID-JSFA502&gt;3.0.CO;2-Z [DOI] [Google Scholar]
  • 30.Russell JB, O’Connor JD, Fox DG, Van Soest PJ, Sniffen CJ. A net carbohydrate and protein system for evaluating cattle diets: I. Ruminal fermentation. J Anim Sci. 1992;70: 3551–3561. 10.2527/1992.70113551x [DOI] [PubMed] [Google Scholar]
  • 31.Bentley Intruments. Bentley 2000: Operator’s Manual. Bentley 2000; 1995a. [Google Scholar]
  • 32.Bentley Intruments. Bentley Chemspeck 150: User’s Guide. Bentley; 1998. [Google Scholar]
  • 33.Bentley Intruments. Bentley Somacount 300: operator’s manual. 1995. b. [Google Scholar]
  • 34.Rodríguez-Ruiz J, Belarbi E-H, Sánchez JLG, Alonso DL. Rapid simultaneous lipid extraction and transesterification for fatty acid analyses. Biotechnology Techniques. 1998;12: 689–691. 10.1023/A:1008812904017 [DOI] [Google Scholar]
  • 35.Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Anal Biochem. 1978;90: 420–426. 10.1016/0003-2697(78)90046-5 [DOI] [PubMed] [Google Scholar]
  • 36.Christie WW. A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J Lipid Res. 1982;23: 1072–1075. [PubMed] [Google Scholar]
  • 37.Saldanha T, Mazalli MR, Bragagnolo N. Avaliação comparativa entre dois métodos para determinação do colesterol em carnes e leite. Food Science and Technology. 2004;24: 109–113. 10.1590/S0101-20612004000100020 [DOI] [Google Scholar]
  • 38.Ulbricht TL, Southgate DA. Coronary heart disease: seven dietary factors. Lancet. 1991;338: 985–992. 10.1016/0140-6736(91)91846-m [DOI] [PubMed] [Google Scholar]
  • 39.Santos-Silva J, Bessa RJB, Santos-Silva F. Effect of genotype, feeding system and slaughter weight on the quality of light lambs: II. Fatty acid composition of meat. Livestock Production Science. 2002;77: 187–194. 10.1016/S0301-6226(02)00059-3 [DOI] [Google Scholar]
  • 40.SAS Enterprise Guide 8.2: User’s Guide. 502.
  • 41.Grummer RR. Effect of Feed on the Composition of Milk Fat. Journal of Dairy Science. 1991;74: 3244–3257. 10.3168/jds.S0022-0302(91)78510-X [DOI] [PubMed] [Google Scholar]
  • 42.Palmquist DL, Jenkins TC. A 100-Year Review: Fat feeding of dairy cows. J Dairy Sci. 2017;100: 10061–10077. 10.3168/jds.2017-12924 [DOI] [PubMed] [Google Scholar]
  • 43.Bauman DE, Griinari JM. Nutritional Regulation of Milk Fat Synthesis. Annu Rev Nutr. 2003;23: 203–227. 10.1146/annurev.nutr.23.011702.073408 [DOI] [PubMed] [Google Scholar]
  • 44.Palmquist DL, Mattos W. Turnover of Lipoproteins and Transfer to Milk Fat of Dietary (1-Carbon-14) Linoleic Acid in Lactating Cows1. Journal of Dairy Science. 1978;61: 561–565. 10.3168/jds.S0022-0302(78)94410-7 [DOI] [Google Scholar]
  • 45.Bauman DE, Harvatine KJ, Lock AL. Nutrigenomics, Rumen-Derived Bioactive Fatty Acids, and the Regulation of Milk Fat Synthesis. Annual Review of Nutrition. 2011;31: 299–319. 10.1146/annurev.nutr.012809.104648 [DOI] [PubMed] [Google Scholar]
  • 46.Lehninger A. Principles Of Biochemistry. New York, NY; 2008. [Google Scholar]
  • 47.Hopkins PN. Effects of dietary cholesterol on serum cholesterol: a meta-analysis and review. Am J Clin Nutr. 1992;55: 1060–1070. 10.1093/ajcn/55.6.1060 [DOI] [PubMed] [Google Scholar]
  • 48.Keeney M, Katz I, Allison MJ. On the probable origin of some milk fat acids in rumen microbial lipids. J Am Oil Chem Soc. 1962;39: 198–201. 10.1007/BF02635818 [DOI] [Google Scholar]
  • 49.Baumann E, Chouinard PY, Lebeuf Y, Rico DE, Gervais R. Effect of lipid supplementation on milk odd- and branched-chain fatty acids in dairy cows. Journal of Dairy Science. 2016;99: 6311–6323. 10.3168/jds.2015-10746 [DOI] [PubMed] [Google Scholar]
  • 50.Maia MRG, Chaudhary LC, Figueres L, Wallace RJ. Metabolism of polyunsaturated fatty acids and their toxicity to the microflora of the rumen. Antonie Van Leeuwenhoek. 2007;91: 303–314. 10.1007/s10482-006-9118-2 [DOI] [PubMed] [Google Scholar]
  • 51.Fievez V, Colman E, Castro-Montoya JM, Stefanov I, Vlaeminck B. Milk odd- and branched-chain fatty acids as biomarkers of rumen function—An update. Animal Feed Science and Technology. 2012;172: 51–65. 10.1016/j.anifeedsci.2011.12.008 [DOI] [Google Scholar]
  • 52.Rego OA, Rosa HJD, Portugal PV, Franco T, Vouzela CM, Borba AES, et al. The effects of supplementation with sunflower and soybean oils on the fatty acid profile of milk fat from grazing dairy cows. Anim Res. 2005;54: 17–24. 10.1051/animres:2005002 [DOI] [Google Scholar]
  • 53.Loor JJ, Ferlay A, Ollier A, Doreau M, Chilliard Y. Relationship among trans and conjugated fatty acids and bovine milk fat yield due to dietary concentrate and linseed oil. J Dairy Sci. 2005;88: 726–740. 10.3168/jds.S0022-0302(05)72736-3 [DOI] [PubMed] [Google Scholar]
  • 54.Grundy SM. Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids. Am J Clin Nutr. 1994;60: 986S–990S. 10.1093/ajcn/60.6.986S [DOI] [PubMed] [Google Scholar]
  • 55.Mensink RP, Zock PL, Kester ADM, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77: 1146–1155. 10.1093/ajcn/77.5.1146 [DOI] [PubMed] [Google Scholar]
  • 56.Caroprese M, Marzano A, Marino R, Gliatta G, Muscio A, Sevi A. Flaxseed supplementation improves fatty acid profile of cow milk. Journal of Dairy Science. 2010;93: 2580–2588. 10.3168/jds.2008-2003 [DOI] [PubMed] [Google Scholar]
  • 57.Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V, et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999;70: 1009–1015. 10.1093/ajcn/70.6.1009 [DOI] [PubMed] [Google Scholar]
  • 58.Pires J a. A, Grummer RR. Specific fatty acids as metabolic modulators in the dairy cow. Revista Brasileira de Zootecnia. 2008;37: 287–298. 10.1590/S1516-35982008001300033 [DOI] [Google Scholar]
  • 59.Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Brazilian Journal of Medical and Biological Research. 2003;36: 433–446. 10.1590/s0100-879x2003000400004 [DOI] [PubMed] [Google Scholar]
  • 60.De Caterina R, Zampolli A. Antiatherogenic effects of n-3 fatty acids—evidence and mechanisms. Heart Int. 2006;2 10.4081/hi.2006.141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA. 2003;100: 1751–1756. 10.1073/pnas.0334211100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis. 1999;20: 2209–2218. 10.1093/carcin/20.12.2209 [DOI] [PubMed] [Google Scholar]
  • 63.Martin CA, Almeida VV de, Ruiz MR, Visentainer JEL, Matshushita M, Souza NE de, et al. Omega-3 and omega-6 polyunsaturated fatty acids: importance and occurrence in foods. Revista de Nutrição. 2006;19: 761–770. 10.1590/S1415-52732006000600011 [DOI] [Google Scholar]
  • 64.Thanh LP, Suksombat W. Milk Yield, Composition, and Fatty Acid Profile in Dairy Cows Fed a High-concentrate Diet Blended with Oil Mixtures Rich in Polyunsaturated Fatty Acids. Asian Australas J Anim Sci. 2015;28: 796–806. 10.5713/ajas.14.0810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Allen MS. Effects of Diet on Short-Term Regulation of Feed Intake by Lactating Dairy Cattle. Journal of Dairy Science. 2000;83: 1598–1624. 10.3168/jds.S0022-0302(00)75030-2 [DOI] [PubMed] [Google Scholar]
  • 66.Kalscheur KF, Teter BB, Piperova LS, Erdman RA. Effect of Fat Source on Duodenal Flow of Trans-C18:1 Fatty Acids and Milk Fat Production in Dairy Cows1, 2. Journal of Dairy Science. 1997;80: 2115–2126. 10.3168/jds.S0022-0302(97)76157-5 [DOI] [PubMed] [Google Scholar]
  • 67.Brown WH, Stull JW, Stott GH. Fatty Acid Composition of Milk. I. Effect of Roughage and Dietary Fat1. Journal of Dairy Science. 1962;45: 191–196. 10.3168/jds.S0022-0302(62)89364-3 [DOI] [Google Scholar]
  • 68.Lubary M, Hofland GW, ter Horst JH. The potential of milk fat for the synthesis of valuable derivatives. Eur Food Res Technol. 2011;232: 1–8. 10.1007/s00217-010-1387-3 [DOI] [Google Scholar]
  • 69.Maynard LJ, Franklin ST. Functional Foods as a Value-Added Strategy: The Commercial Potential of “Cancer-Fighting” Dairy Products. Appl Econ Perspect Policy. 2003;25: 316–331. 10.1111/1467-9353.00141 [DOI] [Google Scholar]
  • 70.Annunziata A, Pascale P. Consumers’ behaviours and attitudes toward healthy food products: The case of organic and functional foods. In: AgEcon Search [Internet]. 2009. [cited 5 Jun 2020]. 10.22004/ag.econ.57661 [DOI] [Google Scholar]

Decision Letter 0

Juan J Loor

8 Oct 2020

PONE-D-20-26797

Inclusion of soybean and linseed oils in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet

PLOS ONE

Dear Dr. Saran Netto,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 22 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for stating the following in the Acknowledgments Section of your manuscript:

[We are grateful to the São Paulo Research Foundation (FAPESP) in São

501 Paulo, Brazil for the research funding (FAPESP Process 2015/ 19393-8) and for the

502 scholarships (FAPESP Processes 2016/23735-4 and 2016/23797-0).]

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 [The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.]

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Please amend the manuscript submission data (via Edit Submission) to include author Mauricio X. S. Oliveira.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: PONE-D-20-26797 is a manuscript dealing with cows fed with two dietary oils and their effect on milk FA profile. Overall, the manuscript has some details that need to be clarified. There is a lack of care in the overall manuscript presentation.

Introduction: please write the specific biological mechanisms whereby dietary FA are shifted into healthy milk FA

Lines 96-98 Please be more specific on your hypothesis, what are the expected changes in individual FA?

Lines 103-106 re write, not sure why are you describing this, also add the reference from the pig study or refer to a code id project or something where we can visualize the overall framework

Lines 114-115 re write, you have one study divided in 10 d for adaptation and 84 d for data collection? But then in lines 120-121 you mentioned that it was 28 days for experimental period with 21 days for adaptation, please clarify

Lines 129-131 ok , but write the rationale behind it, what was the theoretical assumptions?

Lines 223-224 write the volumes per animal per collection period

Results: in tis section please add C for each individual FA

Line 311 change to Blood metabolites

LINE 328 add reference

Line 330 add reference

Lines 333-339 re write the paragraph, it seems very intricate

DISCUSSION:

Authors have discussed the observed changes superficially, please at each subsection or data set, explain the biological mechanisms behind the results. You worked with ruminants and their lipid metabolism is the key point whereby the observed changes are explain.

CONCLUSION:

Make it in 3-4 lines, explain overall result and implications of your study.

Tables: sometimes is c and sometimes is C, please use C for fatty acids nomenclature

Table 1 is it % of dry matter, please write it down

Table 2 use 2 decimals,

Table 3 use 2 decimals and explain which unit you are using

Reviewer #2: The study was done to with the objective of producing milk with fatty acid composition that is healthier for human consumption by dietary inclusion of soybean oil and linseed oil in the dairy cow diets. The results from the study confirm earlier reports that inclusion of oil in the dairy diets reduce the feed intake, decreases milk fat and alters milk fatty acid profile.

Main Questions:

1. Pl. elaborates how this study is different from the earlier studies with supplementation of different types of oils in the diet? There are numerous studies in the area that have been done using the oil supplementation. Summarise these and compare your results.

2. How did you decide on the levels of the supplemental oil in the experiment??

3. In the tables, indicate the differences between the treatments by using the different alphabets to each treatment when there are significant differences.

Minor comments:

Line 61. Change to “increase in blood….”

Line 69. Pl. be more specific. From which year and in which of the countries??

Line 105-106. Have you included any data related to evaluation of milk in the pig model? If not, remove the sentence and include the statement in the conclusion as future directions.

Line 123-130. Give brief explanation as to how the levels of oil inclusion were decided? Give suitable references.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 9;16(2):e0246357. doi: 10.1371/journal.pone.0246357.r002

Author response to Decision Letter 0


19 Nov 2020

Response to Reviewers Comments

Reviewers one and two:

AU: Thank you for your kind words and affirmation that this study is relevant and important. We greatly appreciate you taking the time to review this manuscript. Your suggestions have improved the manuscript immensely.

Reviewer one:

Reviewer #1: PONE-D-20-26797 is a manuscript dealing with cows fed with two dietary oils and their effect on milk FA profile. Overall, the manuscript has some details that need to be clarified. There is a lack of care in the overall manuscript presentation.

AU: The authors agree that there were some details missing in the first submission. We have worked on your detailed remarks and we believe you will find it clarifying. In the first submission, we focused our discussion on the nutritional quality of milk on a human perspective. Nevertheless, the authors agree that extending the discussion section by explaining more on the ruminant lipid metabolism is beneficial to the manuscript. Hopefully you will find this second version more tidily. Please see more details bellow.

Introduction: please write the specific biological mechanisms whereby dietary FA are shifted into healthy milk FA

AU: We have added a new section explaining this specific mechanism. Please find this newly added information on lines 91-101.

Lines 96-98 Please be more specific on your hypothesis, what are the expected changes in individual FA?

AU: We have clearly stated that on our hypothesis and this change is found on lines 105-109.

Lines 103-106 re write, not sure why are you describing this, also add the reference from the pig study or refer to a code id project or something where we can visualize the overall framework

AU: We have now realized the mentioning the second study is causing much confusion on the reader’s perspective. Hence, we have decided to follow reviewer #2 advice and remove the mentions from the swine model on the body of the text and simply include a short statement in the conclusion as future directions. Because of that, we will not be adding a reference to the study. Finally, the swine manuscript is currently under review. Unfortunately, until the manuscript is published, you will only be able to find the Mater’s thesis published on the native language of where the study was conducted (https://www.teses.usp.br/teses/disponiveis/74/74131/tde-07052019-075412/publico/ME9691119COR.pdf). The abstract section is written in the English.

Lines 114-115 re write, you have one study divided in 10 d for adaptation and 84 d for data collection? But then in lines 120-121 you mentioned that it was 28 days for experimental period with 21 days for adaptation, please clarify

AU: We realize that this is confusing and could have been better explained: the very first 10 days of study was designated to adapt the animals to the newly modified environment, which consisted of the stalls, divided by electric fences, in which they were kept during the whole study. At this time, all animals were fed the same diet. After the first ten days, each animal received its designated experimental diet from the Latin square design. There were three treatment diets and hence, three experimental periods consisting of 28 days each, which equals a total experimental period of 84 days. The first 21 days were used to adapt the animals to the new diet, and the last seven days of each experimental period were used to data collection. You will find adjustments to the manuscript from line 123 to line 129.

Lines 129-131 ok , but write the rationale behind it, what was the theoretical assumptions?

AU: See rationale on lines 141-142.

Lines 223-224 write the volumes per animal per collection period

AU: The volumes were added to the main text and you can see the details on line 238 to 240.

Results: in tis section please add C for each individual FA

AU: We have fixed that issue in the Results section (line 280 to 357) and throughout the manuscript.

Line 311 change to Blood metabolites

AU: Agreed. See changes on line 342 and 521.

LINE 328 add reference

AU: Reference has been added and can be find on line 361.

Line 330 add reference

AU: Reference has been added and can be find on line 363.

Lines 333-339 re write the paragraph, it seems very intricate

AU: As we explained before, we realize that mentioning the swine model in this paper is causing confusion on readers. Because of that, the authors have decided to follow the instruction from reviewer two and remove the mentions from the swine model on the body of the text and simply include a statement in the conclusion as future directions.

DISCUSSION:

Authors have discussed the observed changes superficially, please at each subsection or data set, explain the biological mechanisms behind the results. You worked with ruminants and their lipid metabolism is the key point whereby the observed changes are explain.

AU: This is a very good suggestion. Because our ultimate goal is to evaluate if the milk produced in this study is beneficial to other species (swine and eventually humans), we focused our discussion on the nutritional quality of milk on a human perspective. Nevertheless, the authors agree that extending the discussion section by explaining more on the ruminant lipid metabolism is beneficial to the manuscript. Hence, in the present version, you will find a more detailed discussion on the de novo synthesis of fatty acids in the mammary gland (lines 370 to 386), the effect of unsaturated fatty acid supplementation on ruminal microbes (lines 395 to 408), ruminal biohydrogenation (lines 409 to 417), overall lipid metabolism in ruminants (lines 425 to 435), and lipid supplementation and its effect of dry matter intake (lines 480 to 496). We realize that these discussions were missing in the first submission and agree that they have enhanced the quality of our manuscript.

CONCLUSION:

Make it in 3-4 lines, explain overall result and implications of your study.

AU: We have shortened the study conclusion. You can see changes starting in line 538. We have decided to follow reviewer #2 advice and remove the mentions from the swine model on the body of the text and simply include a short statement in the conclusion as future directions. Because of that, our conclusion is a little over the suggested 3-4 lines.

Tables: sometimes is c and sometimes is C, please use C for fatty acids nomenclature

AU: This has been fixed. You can see the changes starting on lines 222 and 290.

Table 1 is it % of dry matter, please write it down

AU: That is correct – the values are expressed in dry matter percentage. We have rewritten the title of table one and the changes can be found on line 146 and 147.

Table 2 use 2 decimals,

AU: The adjustments have been made. You will find the changes on line 222 to 224.

Table 3 use 2 decimals and explain which unit you are using

AU: The adjustments have been made. You will find the changes starting on lines 289 to 292.

Reviewer two

Reviewer #2: The study was done to with the objective of producing milk with fatty acid composition that is healthier for human consumption by dietary inclusion of soybean oil and linseed oil in the dairy cow diets. The results from the study confirm earlier reports that inclusion of oil in the dairy diets reduce the feed intake, decreases milk fat and alters milk fatty acid profile.

AU: Thank you so much for taking the time to review our manuscript. Please see comments for specific remarks below.

Main Questions:

1. Pl. elaborates how this study is different from the earlier studies with supplementation of different types of oils in the diet? There are numerous studies in the area that have been done using the oil supplementation. Summarise these and compare your results.

AU: This is a good question. Indeed, the present study was performed to provide additional evidence of the effects of oil supplementation on the fat fraction of milk from dairy cows. We realize that the literature on oil supplementation is not scarce worldwide; however, there are much fewer publications in the literature describing the results of trials that evaluated oils under tropical conditions. Moreover, unlike other studies, the present research was carried out concomitantly with another animal nutrition trial. We evaluated the effects of feeding the milk produced in the present study on the health and reproduction of female Sus scrofa domesticus and their offspring. Once we have this study and the swine study, our next step is to compare the omega-3, omega-6 and the control milk in the human diet. It is our understanding that very few studies in the available literature have evaluated the effects of naturally enhanced milk on health parameters of other species. On the other hand, we realize that mentioning the swine model in this paper is causing confusion on readers. Because of that, the authors have decided to follow your instruction and remove the mentions from the swine model on the body of the text and simply include a statement in the conclusion as future directions.

Finally, in this new version, you will find a more detailed discussion on the results from the present study and previous studies (lines 370 to 386; lines 395 to 408; lines 409 to 417; 480 to 496, and finally, 499 to 510).

2. How did you decide on the levels of the supplemental oil in the experiment??

AU: The 2.5% level of inclusion of oil in the total dry matter was decided based on previous studies from our research group. In the past, we have evaluated both 3% and 6% (Welter et al., 2016) our 4% (Salles et al., 2019) of vegetable oils in the DM of dairy cows. We have observed a decrease in dry mater intake and subsequent decrease in milk yield (Welter et al., 2016) when using 3 or 6% of oil and also a decrease on the protein content of milk (Salles et al., 2019).

Finally, findings from a different research group (Benchaar et al., 2012) suggested that including up to 2.5% of linseed oil could be safely supplemented to forage-based diets of dairy cows to enrich milk with potential health-beneficial fatty acid with little detrimental effect on digestion, rumen function, and animal performance.

3. In the tables, indicate the differences between the treatments by using the different alphabets to each treatment when there are significant differences.

AU: The authors have taken your suggestion into consideration and carefully discussed the possibility of using letters to indicate statistical difference between treatments. However, it is our understanding that using different letters whenever a treatment is significantly different is what is done under a multiple comparison statistical analysis. On the other hand, considering that on our data we performed orthogonal contrasts (OC), we believe that simply adding alphabets letters to each treatment means would not be appropriate.

Our treatment groups are structured (NO oil, PRESENCE of soybean oil, PRESENCE of linseed oil), and we believe the OC evaluation is the most appropriate. Our structure is based on the evaluation of the “presence of oil in the diet” (contrast one) and “the two oil types” (contrast two). The OC analysis not only informs us about the differences in treatments (like a multiple comparison analysis would), but it has hr advantage of allowing us to explore a whole relationship that would not otherwise be addressable.

If you believe that OC is not the appropriate way to go here, please let us know and we will reconsider changing the OC analysis to a multiple comparison test.

Minor comments:

Line 61. Change to “increase in blood….”

AU: We have corrected that. See changes on line 58.

Line 69. Pl. be more specific. From which year and in which of the countries??

AU: We have modified that statement and provided suitable reference. You can find that on lines 66 to 68.

Line 105-106. Have you included any data related to evaluation of milk in the pig model? If not, remove the sentence and include the statement in the conclusion as future directions.

AU: We realize that mentioning the pig model in this paper is causing confusion on readers. Because of that, the authors have decided to follow the your instruction and remove the mentions from the swine model on the body of the text and simply include a statement in the conclusion as future directions

Line 123-130. Give brief explanation as to how the levels of oil inclusion were decided? Give suitable references.

We have added that information with proper reference to lines 135 to 137.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Juan J Loor

18 Jan 2021

Inclusion of soybean and linseed oils in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet

PONE-D-20-26797R1

Dear Dr. Saran Netto,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Juan J Loor

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Authors have done changes accordingly

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Einar Vargas-Bello-Pérez

Acceptance letter

Juan J Loor

25 Jan 2021

PONE-D-20-26797R1

Inclusion of soybean and linseed oils in the diet of lactating dairy cows makes the milk fatty acid profile nutritionally healthier for the human diet

Dear Dr. Netto:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Juan J Loor

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES